Detalhe da pesquisa
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587254
2.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587237
3.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.
Circulation
; 149(21): 1627-1638, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581389
4.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med
; 384(2): 105-116, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185990
5.
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI.
Cardiovasc Drugs Ther
; 37(5): 941-953, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567726
6.
Global Variations in Heart Failure Etiology, Management, and Outcomes.
JAMA
; 329(19): 1650-1661, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191704
7.
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 143(12): 1215-1223, 2021 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33461308
8.
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med
; 380(16): 1509-1524, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883055
9.
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial.
Am Heart J
; 251: 1-12, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533724
10.
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
Eur Heart J
; 42(31): 2995-3007, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963372
11.
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
Eur Heart J
; 42(31): 3011-3020, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080008
12.
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
Lancet
; 396(10266): 1895-1904, 2020 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33197395
13.
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
Eur Heart J
; 41(42): 4114-4123, 2020 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820320
14.
Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
Circulation
; 140(2): 103-112, 2019 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31117810
15.
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Lancet
; 394(10204): 1169-1180, 2019 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484629
16.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
N Engl J Med
; 377(14): 1319-1330, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844192
17.
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Gastroenterology
; 157(2): 403-412.e5, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054846
18.
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Gastroenterology
; 157(3): 682-691.e2, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152740
19.
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
J Cardiovasc Pharmacol
; 76(1): 4-22, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32639325
20.
ß-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study.
Eur Heart J
; 40(18): 1399-1407, 2019 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30590529